![Paul Moore](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Moore
Technik-/Wissenschafts-/F&E-Leiter bei
ZYMEWORKS INC.
Vermögen: 1 Mio $ am 31.08.2026
Profil
Paul A. Moore is Chief Scientific Officer at Zymeworks BC, Inc. and Zymeworks, Inc., both positions starting in 2022.
Former roles include Director-Lead Product Development at Human Genome Sciences, Inc., Director-Cell Biology at Celera Corp.
from 2005 to 2008, and Vice President-Cell Biology & Immunology at MacroGenics, Inc. from 2008 to 2022.
Education includes a doctorate from the University of Glasgow and an undergraduate degree from the University of Strathclyde.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ZYMEWORKS INC. 0.07% | 12.01.2026 | 48’497 ( 0.07% ) | 1 Mio $ | 31.08.2026 |
Aktive Positionen von Paul Moore
| Unternehmen | Position | Beginn |
|---|---|---|
| ZYMEWORKS INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2022 |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Technik-/Wissenschafts-/F&E-Leiter | 18.07.2022 |
Ehemalige bekannte Positionen von Paul Moore
| Unternehmen | Position | Ende |
|---|---|---|
| MACROGENICS, INC. | Corporate Officer/Principal | 01.07.2022 |
Celera Corp.
 Celera Corp. Medical/Nursing ServicesHealth Services Provides medical diagnostic services | Corporate Officer/Principal | 01.04.2008 |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Corporate Officer/Principal | - |
Ausbildung von Paul Moore
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
59
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Health Technology |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Health Technology |
Celera Corp.
Celera Corp. Medical/Nursing ServicesHealth Services Provides medical diagnostic services | Health Services |
University of Glasgow
 University of Glasgow Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MacroGenics, Inc.
 MacroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes antibody-based therapeutics for the treatment of cancer | Health Technology |
University of Strathclyde
 University of Strathclyde Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zymeworks, Inc.
 Zymeworks, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
